Remote, Smart Device-Based Cardiac Rehabilitation After Myocardial Infarction: A Pilot, Randomized Cross-Over SmartRehab Study
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11110%2F24%3A10486697" target="_blank" >RIV/00216208:11110/24:10486697 - isvavai.cz</a>
Alternative codes found
RIV/00216208:11120/24:43927660
Result on the web
<a href="https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=kb7ztdKWvw" target="_blank" >https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=kb7ztdKWvw</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1016/j.mcpdig.2024.06.001" target="_blank" >10.1016/j.mcpdig.2024.06.001</a>
Alternative languages
Result language
angličtina
Original language name
Remote, Smart Device-Based Cardiac Rehabilitation After Myocardial Infarction: A Pilot, Randomized Cross-Over SmartRehab Study
Original language description
Objective: To evaluate the effect of smart device-based telerehabilitation on VO2peak in patients after myocardial infarction. Patients and Methods: This was a pilot, single-center, randomized, cross-over study with a 3-month intervention. One month after myocardial infarction, patients had cardiopulmonary exercise testing and a 6-minute walking test (6MWT) and were randomly assigned 1:1. In the intervention group, patients received a smartwatch to track the recommended number of steps, which was individualized and derived from the 6MWT. A study nurse telemonitored adherence to the recommended number of steps a day. In the control group, 150 minutes a week of moderate-intensity physical activity was recommended. After 3 months study arms were crossed over, and study procedures were repeated after 3 months. Results: Between June 1, 2019, and February 28, 2023, 64 patients were randomized, of which 61 (aged 51±10 years, 10% women) completed the study. Overall, the smart device-based telerehabilitation led to 2.31 mL/kg/min (95% CI, 1.25-3.37; P<.001) VO2peak increase compared with the control treatment. Furthermore, there was a significant effect on weight (−1.50 kg; 95% CI, −0.39 to −2.70), whereas the effect on the 6MWT distance (4.7 m; 95% CI, −11.8 to 21.1) or Kansas City Quality of Life questionnaire score (0.98; 95% CI, −1.38 to 3.35) was not significant. Conclusion: Smart device-based cardiac rehabilitation may be a promising alternative for patients unable or unwilling to attend in-person cardiac rehabilitation. Trial Registration: clinicaltrials.gov Identifier: NCT03926312
Czech name
—
Czech description
—
Classification
Type
J<sub>SC</sub> - Article in a specialist periodical, which is included in the SCOPUS database
CEP classification
—
OECD FORD branch
30201 - Cardiac and Cardiovascular systems
Result continuities
Project
<a href="/en/project/LX22NPO5104" target="_blank" >LX22NPO5104: National Institute for Research of Metabolic and Cardiovascular Diseases</a><br>
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)
Others
Publication year
2024
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Mayo Clinic Proceedings. Digital Health
ISSN
2949-7612
e-ISSN
2949-7612
Volume of the periodical
2
Issue of the periodical within the volume
3
Country of publishing house
US - UNITED STATES
Number of pages
9
Pages from-to
352-360
UT code for WoS article
—
EID of the result in the Scopus database
2-s2.0-85206127831